Global Eye Disease Stem Cell Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032

January 2026 | 118 pages | ID: GE18EC5F0A0DEN
GlobalInfoResearch

Abstracts

According to our (Global Info Research) latest study, the global Eye Disease Stem Cell Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.

The Eye Disease Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Eye Disease Stem Cell Therapy market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type,

• Autologous
• Allogeneic

Market segment by Application

• Preclinical
• Clinical Phase 1,2

Market segment by players, this report covers

• Lineage Cell Therapeutics
• Astellas Pharma
• Riken
• Sumitomo Chemical
• Senju Pharmaceutical
• Healios
• Centre National de la Recherche Scientifique
• Mayo Clinic
• Intellia Therapeutics
• Neurotech USA
• Ecole Normale Sup?rieure de Paris
• Eyestem Research
• EyeCyte

Market segment by regions, regional analysis covers

North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)
South America
Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Eye Disease Stem Cell Therapy
1.2 Classification of Eye Disease Stem Cell Therapy by Type
  1.2.1 Overview: Global Eye Disease Stem Cell Therapy Market Size by Type: 2026 Versus 2032
  1.2.2 Global Eye Disease Stem Cell Therapy Revenue Market Share by Type in 2032
  1.2.3 Autologous
  1.2.4 Allogeneic
1.3 Global Eye Disease Stem Cell Therapy Market by Application
  1.3.1 Overview: Global Eye Disease Stem Cell Therapy Market Size by Application: 2026 Versus 2032
  1.3.2 Preclinical
  1.3.3 Clinical Phase 1,2
1.4 Global Eye Disease Stem Cell Therapy Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Eye Disease Stem Cell Therapy Market Drivers
  1.5.2 Eye Disease Stem Cell Therapy Market Restraints
  1.5.3 Eye Disease Stem Cell Therapy Trends Analysis

2 COMPANY PROFILES

2.1 Lineage Cell Therapeutics
  2.1.1 Lineage Cell Therapeutics Details
  2.1.2 Lineage Cell Therapeutics Major Business
  2.1.3 Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Product and Solutions
  2.1.4 Lineage Cell Therapeutics Recent Developments and Future Plans
2.2 Astellas Pharma
  2.2.1 Astellas Pharma Details
  2.2.2 Astellas Pharma Major Business
  2.2.3 Astellas Pharma Eye Disease Stem Cell Therapy Product and Solutions
  2.2.4 Astellas Pharma Recent Developments and Future Plans
2.3 Riken
  2.3.1 Riken Details
  2.3.2 Riken Major Business
  2.3.3 Riken Eye Disease Stem Cell Therapy Product and Solutions
  2.3.4 Riken Recent Developments and Future Plans
2.4 Sumitomo Chemical
  2.4.1 Sumitomo Chemical Details
  2.4.2 Sumitomo Chemical Major Business
  2.4.3 Sumitomo Chemical Eye Disease Stem Cell Therapy Product and Solutions
  2.4.4 Sumitomo Chemical Recent Developments and Future Plans
2.5 Senju Pharmaceutical
  2.5.1 Senju Pharmaceutical Details
  2.5.2 Senju Pharmaceutical Major Business
  2.5.3 Senju Pharmaceutical Eye Disease Stem Cell Therapy Product and Solutions
  2.5.4 Senju Pharmaceutical Recent Developments and Future Plans
2.6 Healios
  2.6.1 Healios Details
  2.6.2 Healios Major Business
  2.6.3 Healios Eye Disease Stem Cell Therapy Product and Solutions
  2.6.4 Healios Recent Developments and Future Plans
2.7 Centre National de la Recherche Scientifique
  2.7.1 Centre National de la Recherche Scientifique Details
  2.7.2 Centre National de la Recherche Scientifique Major Business
  2.7.3 Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Product and Solutions
  2.7.4 Centre National de la Recherche Scientifique Recent Developments and Future Plans
2.8 Mayo Clinic
  2.8.1 Mayo Clinic Details
  2.8.2 Mayo Clinic Major Business
  2.8.3 Mayo Clinic Eye Disease Stem Cell Therapy Product and Solutions
  2.8.4 Mayo Clinic Recent Developments and Future Plans
2.9 Intellia Therapeutics
  2.9.1 Intellia Therapeutics Details
  2.9.2 Intellia Therapeutics Major Business
  2.9.3 Intellia Therapeutics Eye Disease Stem Cell Therapy Product and Solutions
  2.9.4 Intellia Therapeutics Recent Developments and Future Plans
2.10 Neurotech USA
  2.10.1 Neurotech USA Details
  2.10.2 Neurotech USA Major Business
  2.10.3 Neurotech USA Eye Disease Stem Cell Therapy Product and Solutions
  2.10.4 Neurotech USA Recent Developments and Future Plans
2.11 Ecole Normale Sup?rieure de Paris
  2.11.1 Ecole Normale Sup?rieure de Paris Details
  2.11.2 Ecole Normale Sup?rieure de Paris Major Business
  2.11.3 Ecole Normale Sup?rieure de Paris Eye Disease Stem Cell Therapy Product and Solutions
  2.11.4 Ecole Normale Sup?rieure de Paris Recent Developments and Future Plans
2.12 Eyestem Research
  2.12.1 Eyestem Research Details
  2.12.2 Eyestem Research Major Business
  2.12.3 Eyestem Research Eye Disease Stem Cell Therapy Product and Solutions
  2.12.4 Eyestem Research Recent Developments and Future Plans
2.13 EyeCyte
  2.13.1 EyeCyte Details
  2.13.2 EyeCyte Major Business
  2.13.3 EyeCyte Eye Disease Stem Cell Therapy Product and Solutions
  2.13.4 EyeCyte Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Eye Disease Stem Cell Therapy Revenue and Share by Players (2026 & 2032)
3.2 Eye Disease Stem Cell Therapy Players Head Office, Products and Services Provided
3.3 Eye Disease Stem Cell Therapy Mergers & Acquisitions
3.4 Eye Disease Stem Cell Therapy New Entrants and Expansion Plans

4 GLOBAL EYE DISEASE STEM CELL THERAPY FORECAST BY REGION

4.1 Global Eye Disease Stem Cell Therapy Market Size by Region: 2026 VS 2032
4.2 Global Eye Disease Stem Cell Therapy Market Size by Region, (2026-2032)
4.3 North America
  4.3.1 Key Companies of Eye Disease Stem Cell Therapy in North America
  4.3.2 Current Situation and Forecast of Eye Disease Stem Cell Therapy in North America
  4.3.3 North America Eye Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.4 Europe
  4.4.1 Key Companies of Eye Disease Stem Cell Therapy in Europe
  4.4.2 Current Situation and Forecast of Eye Disease Stem Cell Therapy in Europe
  4.4.3 Europe Eye Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.5 Asia-Pacific
  4.5.1 Key Companies of Eye Disease Stem Cell Therapy in Asia-Pacific
  4.5.2 Current Situation and Forecast of Eye Disease Stem Cell Therapy in Asia-Pacific
  4.5.3 Asia-Pacific Eye Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Eye Disease Stem Cell Therapy in South America
  4.6.2 Current Situation and Forecast of Eye Disease Stem Cell Therapy in South America
  4.6.3 South America Eye Disease Stem Cell Therapy Market Size and Prospect (2026-2032)
4.7 Middle East & Africa
  4.7.1 Key Companies of Eye Disease Stem Cell Therapy in Middle East & Africa
  4.7.2 Current Situation and Forecast of Eye Disease Stem Cell Therapy in Middle East & Africa
  4.7.3 Middle East & Africa Eye Disease Stem Cell Therapy Market Size and Prospect (2026-2032)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Eye Disease Stem Cell Therapy Market Forecast by Type (2026-2032)
5.2 Global Eye Disease Stem Cell Therapy Market Share Forecast by Type (2026-2032)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Eye Disease Stem Cell Therapy Market Forecast by Application (2026-2032)
6.2 Global Eye Disease Stem Cell Therapy Market Share Forecast by Application (2026-2032)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Eye Disease Stem Cell Therapy Revenue by Type, (USD Million) 2026 VS 2032
Table 2. Global Eye Disease Stem Cell Therapy Revenue by Application, (USD Million), 2026 VS 2032
Table 3. Lineage Cell Therapeutics Corporate Information, Head Office, and Major Competitors
Table 4. Lineage Cell Therapeutics Major Business
Table 5. Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Product and Solutions
Table 6. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Major Business
Table 8. Astellas Pharma Eye Disease Stem Cell Therapy Product and Solutions
Table 9. Riken Corporate Information, Head Office, and Major Competitors
Table 10. Riken Major Business
Table 11. Riken Eye Disease Stem Cell Therapy Product and Solutions
Table 12. Sumitomo Chemical Corporate Information, Head Office, and Major Competitors
Table 13. Sumitomo Chemical Major Business
Table 14. Sumitomo Chemical Eye Disease Stem Cell Therapy Product and Solutions
Table 15. Senju Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 16. Senju Pharmaceutical Major Business
Table 17. Senju Pharmaceutical Eye Disease Stem Cell Therapy Product and Solutions
Table 18. Healios Corporate Information, Head Office, and Major Competitors
Table 19. Healios Major Business
Table 20. Healios Eye Disease Stem Cell Therapy Product and Solutions
Table 21. Centre National de la Recherche Scientifique Corporate Information, Head Office, and Major Competitors
Table 22. Centre National de la Recherche Scientifique Major Business
Table 23. Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Product and Solutions
Table 24. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 25. Mayo Clinic Major Business
Table 26. Mayo Clinic Eye Disease Stem Cell Therapy Product and Solutions
Table 27. Intellia Therapeutics Corporate Information, Head Office, and Major Competitors
Table 28. Intellia Therapeutics Major Business
Table 29. Intellia Therapeutics Eye Disease Stem Cell Therapy Product and Solutions
Table 30. Neurotech USA Corporate Information, Head Office, and Major Competitors
Table 31. Neurotech USA Major Business
Table 32. Neurotech USA Eye Disease Stem Cell Therapy Product and Solutions
Table 33. Ecole Normale Sup?rieure de Paris Corporate Information, Head Office, and Major Competitors
Table 34. Ecole Normale Sup?rieure de Paris Major Business
Table 35. Ecole Normale Sup?rieure de Paris Eye Disease Stem Cell Therapy Product and Solutions
Table 36. Eyestem Research Corporate Information, Head Office, and Major Competitors
Table 37. Eyestem Research Major Business
Table 38. Eyestem Research Eye Disease Stem Cell Therapy Product and Solutions
Table 39. EyeCyte Corporate Information, Head Office, and Major Competitors
Table 40. EyeCyte Major Business
Table 41. EyeCyte Eye Disease Stem Cell Therapy Product and Solutions
Table 42. Global Eye Disease Stem Cell Therapy Revenue (USD Million) by Players (2026 & 2032)
Table 43. Global Eye Disease Stem Cell Therapy Revenue Share by Players (2026 & 2032)
Table 44. Eye Disease Stem Cell Therapy Players Head Office, Products and Services Provided
Table 45. Eye Disease Stem Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 46. Eye Disease Stem Cell Therapy New Entrants and Expansion Plans
Table 47. Global Market Eye Disease Stem Cell Therapy Revenue (USD Million) Comparison by Region (2026 VS 2032)
Table 48. Global Eye Disease Stem Cell Therapy Revenue Market Share by Region (2026-2032)
Table 49. Key Companies of Eye Disease Stem Cell Therapy in North America
Table 50. Current Situation and Forecast of Eye Disease Stem Cell Therapy in North America
Table 51. Key Companies of Eye Disease Stem Cell Therapy in Europe
Table 52. Current Situation and Forecast of Eye Disease Stem Cell Therapy in Europe
Table 53. Key Companies of Eye Disease Stem Cell Therapy in Asia-Pacific
Table 54. Current Situation and Forecast of Eye Disease Stem Cell Therapy in Asia-Pacific
Table 55. Key Companies of Eye Disease Stem Cell Therapy in China
Table 56. Key Companies of Eye Disease Stem Cell Therapy in Japan
Table 57. Key Companies of Eye Disease Stem Cell Therapy in South Korea
Table 58. Key Companies of Eye Disease Stem Cell Therapy in South America
Table 59. Current Situation and Forecast of Eye Disease Stem Cell Therapy in South America
Table 60. Key Companies of Eye Disease Stem Cell Therapy in Middle East & Africa
Table 61. Current Situation and Forecast of Eye Disease Stem Cell Therapy in Middle East & Africa
Table 62. Global Eye Disease Stem Cell Therapy Revenue Forecast by Type (2026-2032)
Table 63. Global Eye Disease Stem Cell Therapy Revenue Forecast by Application (2026-2032)

List Of Figures

LIST OF FIGURES

Figure 1. Eye Disease Stem Cell Therapy Picture
Figure 2. Global Eye Disease Stem Cell Therapy Revenue Market Share by Type in 2032
Figure 3. Autologous
Figure 4. Allogeneic
Figure 5. Eye Disease Stem Cell Therapy Revenue Market Share by Application in 2032
Figure 6. Preclinical Picture
Figure 7. Clinical Phase 1,2 Picture
Figure 8. Global Eye Disease Stem Cell Therapy Market Size, (USD Million): 2026 VS 2032
Figure 9. Global Eye Disease Stem Cell Therapy Revenue and Forecast (2026-2032) & (USD Million)
Figure 10. Eye Disease Stem Cell Therapy Market Drivers
Figure 11. Eye Disease Stem Cell Therapy Market Restraints
Figure 12. Eye Disease Stem Cell Therapy Market Trends
Figure 13. Lineage Cell Therapeutics Recent Developments and Future Plans
Figure 14. Astellas Pharma Recent Developments and Future Plans
Figure 15. Riken Recent Developments and Future Plans
Figure 16. Sumitomo Chemical Recent Developments and Future Plans
Figure 17. Senju Pharmaceutical Recent Developments and Future Plans
Figure 18. Healios Recent Developments and Future Plans
Figure 19. Centre National de la Recherche Scientifique Recent Developments and Future Plans
Figure 20. Mayo Clinic Recent Developments and Future Plans
Figure 21. Intellia Therapeutics Recent Developments and Future Plans
Figure 22. Neurotech USA Recent Developments and Future Plans
Figure 23. Ecole Normale Sup?rieure de Paris Recent Developments and Future Plans
Figure 24. Eyestem Research Recent Developments and Future Plans
Figure 25. EyeCyte Recent Developments and Future Plans
Figure 26. Global Eye Disease Stem Cell Therapy Revenue Market Share by Region (2026-2032)
Figure 27. Global Eye Disease Stem Cell Therapy Revenue Market Share by Region in 2032
Figure 28. North America Eye Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 29. Europe Eye Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 30. Asia-Pacific Eye Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 31. South America Eye Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 32. Middle East & Africa Eye Disease Stem Cell Therapy Revenue (USD Million) and Growth Rate (2026-2032)
Figure 33. Global Eye Disease Stem Cell Therapy Market Share Forecast by Type (2026-2032)
Figure 34. Global Eye Disease Stem Cell Therapy Market Share Forecast by Application (2026-2032)
Figure 35. Methodology
Figure 36. Research Process and Data Source